Lennham Presents Topline Data From Human PK Study of D9-Caffeine vs Caffeine at ISSN 2021

Jun 18

Written By Corey MacGregor

View the poster presentation here.

Corey MacGregor

Lennham Pharmaceuticals Expands Leading Psilocybin Patent Portfolio with Addition of New Patent Family

Lennham Pharmaceuticals Announces Topline Results from Pharmacokinetic Study of D9-Caffeine Versus Caffeine